Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS
1972 • 1,130 citations
Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors
1973 • 184 citations
Etoposide (VP-16-213)
1979 • 151 citations
The podophyllotoxin derivatives VP16-213 and VM26
1982 • 146 citations
Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.
1975 • 133 citations
Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer
1982 • 107 citations
Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213.
1976 • 102 citations
Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.
1976 • 102 citations
Podophyllotoxin derivative VP 16-213
1979 • 86 citations
A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry
1981 • 48 citations
VP16-213 and podophyllotoxin
1982 • 44 citations
In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma
1982 • 29 citations
DNA content distribution of in vivo and in vitro lines of Lewis lung carcinoma
1982 • 13 citations
Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia
1982 • 13 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database